Fortress Biotech, Inc. - Common Stock (FBIO)

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Fortress Biotech (NASDAQ: FBIO) saw its stock plunge over 30% on October 1, 2025, following the U.S. Food and Drug Administration's (FDA) issuance of a Complete Response Letter (CRL) for its New Drug Application (NDA) for CUTX-101. This investigational treatment, developed for pediatric patients suffering from the rare genetic

In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 blocker for advanced cSCC.

Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million registered direct offering and concurrent private placements.

FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Mustang Bio shares soar 190.9% on high trading volume as Phase 1/2 trial data for CAR T-cell therapy MB-106 shows positive results.

FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.